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Background: Abnormalities in nocturnal blood pressure dipping are well known for its relationship to cardiovascular
diseases. Cerebral microbleeds are frequently observed in patients with hypertension and are known to be potent
risk factors for stroke. However, there are scanty reports about the relationship between nocturnal dipping and
cerebral microbleeds.
Methods: We recruited consecutive patients with both hypertension and ischemic stroke within 7 days after
symptom onset, and those with cardioembolism were excluded. We applied 24-hour ambulatory blood pressure
monitoring two weeks after stroke onset, and we used brain MRI to detect cerebral microbleeds. Various blood
pressure parameters such as mean 24-hour blood pressure, awake/sleep blood pressure, and morning surge were
compared between cerebral microbleeds (+) vs. (−) groups. Subjects were further classified according to nocturnal
dipping status and were analyzed by logistic regression to determine its association with cerebral microbleeds
with adjustment for age, gender, and cardiovascular risk factors.
Results: A total of 162 patients (100 males, age 65.33 ± 10.32 years) were included. Cerebral microbleeds were
detected in 65 patients (40.1%). Most ambulatory blood pressure parameters except morning surge were significantly
higher in those who had cerebral microbleeds. After adjusting for the confounding factors, the reverse dippers were
prone to have cerebral microbleeds (odds ratio, 3.81; 95% confidential interval, 1.36-10.65; p-value = 0.01).
Conclusion: Cerebral microbleeds are independently associated with reverse dipping on ambulatory blood pressure
monitoring in hypertensive stroke patients.
Keyword: Ambulatory blood pressure monitoring, Cerebral microbleeds, Cerebrovascular disease,
Cerebral ischemia, HypertensionBackground
Cardiovascular events such as stroke, myocardial infarc-
tion, and sudden cardiac death showed diurnal variations
in their occurrences [1]. Based on these epidemiological
data, ambulatory blood pressure monitoring (ABPM)
was introduced to clinical practice and various research
fields to determine the exact effect of diurnal variation
of blood pressure (BP) on damage to hypertensive target* Correspondence: rophe.pneuma@gmail.com; hwnam@brm.co.kr
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reproduction in any medium, provided the ororgans [2-5]. Among the various reported ABPM pro-
files, non-dippers and reverse dippers are variably asso-
ciated with cerebrovascular diseases [5-7].
Cerebral microbleeds (CMB) are known as focal accumu-
lations of hemosiderin-containing macrophages in the peri-
vascular spaces of small blood vessels in the brain, which
result from blood extravasation, due to microvasculature
structural changes in the brain caused by a high BP load
[8]. This is regarded as a hypertensive target organ dis-
ease in the brain akin to leukoaraiosis and silent brain
infarctions [9,10]. However, as far as we know, there are no
reports evaluating the association between CMB and noc-
turnal dipping patterns in stroke patients. We conductedtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Subjects who had cerebral infarctions within one week
were consecutively recruited from two university hospi-
tals - from August 2007 to July 2011, according to the
following criteria. (Table 1) Regarding exclusion criteria,
we excluded stroke patients under the age of 35 because
they had the possibility to have uncommon causes of
stroke such as connective tissue disease, migraine-related
stroke, and moyamoya disease. We also excluded patients
with systolic blood pressure > 220 mmHg, or diastolic
blood pressure > 120 mmHg because our practice guide-
line suggests antihypertensive medication in those situa-
tions and we wanted to avoid any bias by the use of
antihypertensive medication during ABPM. Patients with
secondary hypertension or patients who underwent intra-
venous thrombolysis were also excluded from the study
because we could not suspend antihypertensive medica-
tions for the possible complications. Patients who suffered
from severe stroke (National Institutes of Health Stroke
Scale ≥ 20) were also excluded because they had the possi-
bility of imprecise evaluation of CMB due to large-sized
infarction and subsequent brain edema.
Stroke diagnosis and treatment were guided using stand-
ard guidelines, and stroke severity was assessed using the
NIHSS. Each stroke etiology was defined by Trial of Org
10172 in Acute Stroke Treatment (TOAST) classifications
[11]. We also included vascular risk factors such as dia-
betes, hyperlipidemia, coronary artery diseases, prior and
current smoking history, and laboratory parameters. We
defined hypertension according to the followings: history ofTable 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion crit
1) Those from 35 to 85 years of age admitted within 7 days
after stroke onset
1) Those aged
2) Those with radiologically-confirmed cerebral infarction in
brain MRI (including T2*-gradient echo MRI)
2) Those with
3) Those with hypertension 3) Those with
gestational, an
4) Those who understand the study protocol and signed the
informed consent
4) Night-shift







Abbreviation: NIHSS (National Institutes of Health Stroke Scale).hypertension and taking antihypertensive medications; or
hypertensive target organ disease - left ventricular hyper-
trophy on electrocardiography or echocardiography, hyper-
tensive retinopathy on the fundus examination; or a BP
measurement of systolic BP over 140 mmHg or diastolic
BP over 90 mmHg at 2 weeks post-symptom onset.
This study was approved by a local institutional review
board with Boramae Hospital; additionally, we obtained
written informed consents from all patients participating
in the study.
24-hour ABPM
Due to possible reactive BP increment after stroke, we
applied ABPM (Oscar 2TM Ambulatory BP monitor,
SunTech Medical, NC, USA) two weeks after the ictus.
Antihypertensive medications were suspended from
stroke ictus per routine clinical protocol. BP was as-
sessed every 30 minutes in the non-paretic upper ex-
tremity. Subjects who obtained less than 80% of valid BP
readings were excluded.
The following parameters were calculated from raw
data for the mean and standard deviations (SD): 24-hour
mean systolic/diastolic BP (SBP/DBP), awake SBP/DBP,
sleep SBP/DBP, morning SBP/DBP, evening SBP/DBP,
lowest sleep SBP/DBP, pre-wake SBP/DBP, morning SBP
surge, nocturnal BP falls, and pulse rate (awake, sleep,
morning, evening, lowest, pre-wake).
Each individual parameter was defined as follows:
Sleep BP was an average of all values from the beginning
of sleep until awakening based on the activity sheet.
Awake BP was defined as the average for the remaining
time excluding sleep BP. Morning BP was designated as
an average BP over 2 hours after awakening. Evening
BP was an average BP during the 2 hours before bed-
time. The lowest sleep BP was defined as an average BP
during 1 hour that included the lowest sleep BP. Pre-eria
< 35, or > 85
systolic blood pressure > 220 mmHg, or diastolic blood pressure > 120 mmHg
secondary hypertension (eg. renal, renovascular, endocrinologic,
d etc.)
workers (sleeping during the day and work from midnight to 4 AM due
r reasons)
were prescribed an intravenous recombinant tissue-plasminogen
ticoagulants
had severe stroke (NIHSS≥ 20)
had life threatening medical conditions (hypertensive encephalopathy,
n, acute myocardial infarction, severe congestive heart failure and etc.)
confirmed cardioembolic risk factors such as atrial fibrillation
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awakening.
Morning BP surge (MBPS) was defined in two different
ways; First, we calculated sleep-trough MBPS as the mean
SBP during the 2 hours after awakening minus the mean
SBP during 1 hour including the lowest SBP during sleep
[12]. Second, pre-wake MBPS was designated as the mor-
ning SBP minus the pre-wake SBP.
Nocturnal BP falls was also defined by two different
means. First, the awake nocturnal fall was calculated as
the awake SBP minus sleep SBP (percentile, relative awake
nocturnal fall = [(1-sleep SBP/awake SBP) * 100]). Second,
the evening nocturnal fall was calculated as the evening
SBP minus sleep BP (percentile, relative evening nocturnal
fall = [(1-sleep SBP/evening SBP) * 100]) [12].
According to the magnitude of the BP falls, subjects were
divided into subgroups: dippers were those who showed
ordinary nocturnal BP falls (10% ≤ nocturnal BP reduc-
tions < 20%), extreme dippers were those who had over
20% nocturnal BP falls, non-dippers were those who did
not meet the ordinary magnitude of BP falls (0% ≤ noctur-
nal BP falls < 10%), and reverse dippers were those who
showed BP increments during nighttime.
Brain MRI
On the day of admission, diffusion-weighted imaging, ap-
parent diffusion coefficient, axial T2, fluid-attenuated
inversion recovery (FLAIR), T2*-gradient echo, sagittal
T1, contrast-enhanced axial/sagittal T1, contrast-enhanced
FLAIR, intracranial and extracranial MR angiography were
obtained for each subject with a 1.5 Tesla supercon-
ducting magnet (MAGNETOM IMPACT EXPERT,
Siemens, Germany). CMB were defined as round-
shaped homogenous foci of low signal intensity lesions
on T2*-weighted gradient echo images, which were less
than 5 mm in diameter [13]. The foci located in the
subarachnoid spaces or symmetrically in the globus palli-
dus were not included, because they were considered as
vessel markings or calcifications. Two neurologists in-
dependently evaluated the locations and numbers of
CMB, without any previous clinical information. The
kappa value of agreement was 0.89, and the locations
and numbers of CMB were coded based on the con-
sensus of the two raters in the cases where there were
any rater discrepancies. The locations of CMB were
classified as lobar, central gray matter (basal ganglia
and thalamus), and infratentorial area (brainstem and
cerebellum) [14].
In addition, acute stroke locations were also reviewed on
diffusion-weighted images. Lesion locations were classified
as cortex, corona radiata, basal ganglia/internal capsule,
and infratentorial. Furthermore, the insular cortex and
amygdala were separately inspected, because there was
prior evidence that disruption of those structures wereassociated with impaired BP variability in patients with
acute stroke [15].
Statistical analysis
We performed Chi-square tests for categorical variables,
and Student’s T-tests for continuous variables. In order
to assess the relationship between various ABPM param-
eters and CMB, we applied logistic regression analyses;
and calculated the odds ratios at one standard deviation
increment in BP parameters. Models were adjusted for
age, gender, and additionally for those which showed
p-value < 0.20 in the bivariable analysis.
Results
A total of 162 subjects were enrolled in this study. Mean
time interval between the ictus of stroke and ABPM was
15.5 days (standard deviation 4.9 days). CMB were de-
tected in 65 (40.1%) patients. About 61% of CMB were
located in the central gray matter, 27% in lobar, and 12%
in infratentorial regions.
Baseline characteristics of subjects with or without
CMB are described in Table 2. CMB were more common
in male patients, and LDL-cholesterol was marginally
lower in subjects with CMB compared to those without
CMB (72.3% vs. 54.6%, p-value = 0.02; 107.2 ± 32.1 vs.
115.7 ± 35.1, p-value = 0.12; for CMB (+) vs. (−) respec-
tively); otherwise, there were no significant differences be-
tween the two groups.
The distribution of stroke lesions is shown in Table 3.
Though cortical infarctions were more common in CMB
(−) patients, there were no significant differences in other
locations including the insular and amygdala regions.
One hundred four (64.2%) subjects had pre-existing
hypertension and 58 were diagnosed with hypertension de
novo. About half of the patients were prescribed antihy-
pertensive medications before index stroke (82 (50.6%) in
total; 34 (52.3%) in CMB (+) patients; 48 (49.5%) in CMB
(−) patients; p = 0.73), and those medications were sus-
pended in all patients after stroke.
Every individual ambulatory BP component in relation
to CMB is presented in Table 2. Most of the BP parame-
ters were significantly higher in subjects with CMB.
When we classified subjects into three groups according
to dipping status, there were 37 (22.8%) and 39 (24.1%)
reverse dippers according to definitions (awake noctur-
nal falls, evening nocturnal falls; respectively) (Table 4).
The risk of CMB was associated with reverse dippers with
an odds ratio of 3.81 (95% confidential interval (CI), 1.36-
10.65; p = 0.01) according to the definition of evening noc-
turnal BP falls, and after adjusting for age, gender, LDL,
and 24-hour mean SBP/DBP. Awake nocturnal BP falls
were not significantly associated with CMB. Additionally,
morning surge did not show any significant differences be-
tween the two groups, according to both definitions.
Table 2 Clinical and BP characteristics of study subjects
Total CMB p- value*
Characteristics Yes No
(n = 162) (n = 65) (n = 97)
Age, years 65.33 ± 10.32 66.23 ± 9.47 64.73 ± 10.85 0.37
Male gender 100 (61.7) 47 (72.3) 53 (54.6) 0.02
DM 36 (22.2) 15 (23.1) 21 (21.6) 0.83
Smokers (current) 49 (30.2) 22 (34.4) 27 (27.8) 0.38
Previous statin use 15 (9.3) 6 (9.5) 9 (9.3) 0.96
Previous antiplatelet use 38 (23.5) 17 (27.4) 21 (21.9) 0.43
Previous antihypertensive medication 82 (50.6) 34 (52.3) 48 (49.5) 0.73
Total cholesterol, mg/dL 180.5 ± 41.5 174.6 ± 38.7 184.4 ± 43.1 0.14
Triglyceride, mg/dL 123.6 ± 82.0 115.0 ± 67.6 129.3 ± 90.1 0.28
LDL-C, mg/dL 112.3 ± 34.1 107.2 ± 32.1 115.7 ± 35.1 0.12
HDL-C, mg/dL 43.1 ± 11.9 44.2 ± 12.2 42.4 ± 11.7 0.35
Homocysteine, mg/dL 12.5 ± 6.2 13.2 ± 5.1 12.0 ± 6.8 0.24
Initial NIHSS 3.35 ± 3.33 3.18 ± 2.92 3.46 ±3.59 0.60
SBP, mmHg
24-hour BP 147.1 ± 15.4 150.8 ± 16.3 144.6 ± 14.2 0.01
Awake BP 149.3 ± 15.9 152.6 ± 17.2 147.0 ± 14.6 0.03
Sleep BP 140.9 ± 17.1 145.9 ± 17.0 137.6 ± 16.5 <0.01
Morning BP 146.5 ± 17.6 149.8 ± 18.0 144.3 ± 17.2 0.05
Evening BP 149.0 ± 20.0 151.9 ± 21.5 147.0 ± 18.8 0.13
Lowest sleep BP 129.8 ± 17.8 133.1 ± 17.8 127.5 ± 17.6 0.05
Pre-wake BP 141.7 ± 18.7 146.1 ± 18.7 138.8 ± 18.2 0.01
DBP, mmHg
24-hour BP 85.2 ± 9.3 88.8 ± 9.9 82.8 ± 8.0 < 0.01
Awake BP 86.7 ± 9.5 90.0 ± 10.2 84.4 ± 8.4 < 0.01
Sleep BP 81.3 ± 10.3 85.8 ± 10.6 78.3 ± 9.0 < 0.01
Morning BP 85.7 ± 12.1 89.7 ± 13.2 83.0 ± 10.6 < 0.01
Evening BP 86.3 ± 12.5 89.6 ± 13.1 84.1 ± 11.6 0.01
Lowest sleep BP 75.6 ± 11.0 78.6 ± 11.2 73.5 ± 10.4 <0.01
Pre-wake BP 81.3 ± 11.1 85.4 ± 11.9 79.5 ± 10.0 < 0.01
Values are presented as ‘mean ± standard deviation.’ For the categorical variables, figures denote frequencies and percentages in parentheses.
*Student’s T-tests for continuous variables and Chi-square tests for categorical variables.
Abbreviations: CMB (cerebral microbleeds), DM (diabetes mellitus), LDL-C (low density lipoprotein-cholesterol), HDL-C (high density lipoprotein-cholesterol), NIHSS
(National Institutes of Health Stroke Scale), SBP (systolic blood pressure), DBP (diastolic blood pressure).
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In this present work, we demonstrated that acute ischemic
stroke patients who had a reverse-dipping phenomenon
were prone to have CMB. Although most of the ABPM
parameters lost their significances after adjusting for the
cardiovascular risk factors and 24-hour mean SBP/DBP,
the association between reverse dipping and CMB was still
significant.
There are few reports that deal with the pathophysiologic
link between dipping and CMB. Pathologically, CMB
are located around the deep perforating arteries showing
moderate to severe lipohyalinosis and amyloid deposits [8].Ruptured arteriosclerotic vessels were also associated
with CMB [7]. Based on these pathologic backgrounds,
we are able to suggest that sustained hypertensive stress to
vascular endothelium, due to reverse dipping during night-
time, could be a plausible explanation for the higher preva-
lence of CMB, though it needs to be confirmed by further
pathologic studies.
In our results, the significant differences were ob-
served only in the reverse dipping with the evening noc-
turnal BP falls, not the awake nocturnal BP falls that is
the conventional definition of nocturnal dipping. Even-
ing nocturnal BP falls were calculated with evening BP
Table 3 Stroke characteristics of subjects
with/without CMB
Total CMB p- value*
Characteristics Yes No
(n = 162) (n = 65) (n = 97)
Stroke subtype 0.26
SVO 92 (56.8) 39 (60.0) 53 (54.6)
LAD 49 (30.2) 17 (26.2) 32 (32.9)
UD 20 (12.3) 9 (13.8) 11 (11.3)
Stroke lesion location†
Insular cortex 11(6.8) 4 (6.2) 7 (7.2) 0.99‡
Amygdala 2 (1.2) 1 (1.5) 1 (1.0) 0.99‡
Cortex 44 (27.2) 11 (16.9) 33 (34.0) 0.02
Corona radiata 62 (38.3) 25 (38.5) 37 (38.1) 0.97
BG/IC 50 (30.9) 19 (29.2) 31 (32.0) 0.71
Thalamus 21 (13.0) 9 (13.8) 12 (12.4) 0.78
Infratentorial 49 (30.2) 21 (32.3) 28 (28.9) 0.64
Parenthesis means proportion in percentage.
*Chi-square test.
†The sum of each cell is not 162, because one could have acute symptomatic
lesions in several locations simultaneously.
‡Fisher’s Exact Test.
Abbreviations: CMB (cerebral microbleeds), SVO (small vessel occlusion), LAD
(large artery disease), UD (undetermined).
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oped this definition a priori by application of Kario’s def-
inition for ‘nocturnal BP fall (mmHg)’. The reason why
we have added novel definition was that comparing sleep
BP with evening BP (2 hours right before falling asleep)Table 4 Ambulatory blood pressure components in relation t
BP component CMB p-value*
Yes (n = 65) No (n = 97)
Morning BP surge
Sleep-trough 16.7 ± 13.8 16.8 ± 14.8 0.96
Pre-wake 3.7 ± 13.4 5.5 ± 14.1 0.41
Awake nocturnal BP falls 0.27§
Dipper 18 (27.7%) 33 (34.0%)
Non-dipper 28 (43.1%) 46 (47.4%)
Reverse dipper 19 (29.2%) 18 (18.6%)
Evening nocturnal BP falls 0.04§
Dipper 14 (21.5%) 33 (34.0%)
Non-dipper 29 (44.6%) 47 (48.5%)
Reverse dipper 22 (33.8%) 17 (17.5%)
Values are presented as mean ± standard deviation.
For the nocturnal BP falls, figures denoted absolute number of cases and percentag
*Independent T-test, unless otherwise specified.
†Logistic regression analysis. Data are presented as the odds ratios (OR) and 95% co
‡Adjusted for age, gender, LDL, 24-hour mean SBP/DBP.
§Chi-square test.
Abbreviations: CMB (cerebral microbleeds), BP (blood pressure).rather than entire awake BP might be more reasonable
to reflect the consequences of nocturnal BP changes,
i.e. more abrupt rise or fall of BP in a short period of time.
Although this definition is different from conventional
one, non-dippers defined by ‘evening nocturnal BP falls’
also showed nocturnal BP increment without normal dip-
ping pattern, which shared the similar biological meaning
with conventional definition. Although this definition was
not used widely, we cautiously suggest that this could be
another way of inspection for nocturnal dipping.
The exact mechanism of reverse dipping is open to
validation. Several explanations such as persistent activa-
tion of autonomic nervous system, sympathetic tone,
and α1-adrenergic activities during the night may ac-
count for this [16]. Sheer stress to the atherosclerotic
cerebral vessel walls increased adrenergic activity, plate-
let activity, and blood viscosity in the early morning
could induce hypercoagulability; and these could further
affect increased vulnerability to stroke [17]. Lesion loca-
tions also could be possible contributing factors for such
phenomena. Patients who had insular lesions showed re-
verse dipping and increased norepinephrine serum levels
[15]. However, in the current study, the frequencies of
insular lesions were not associated with ABPM profiles.
The prevalence of CMB was higher than the previous
studies in hypertensive patients [18], cross-sectional co-
horts [19], or lacunar stroke population [20]. However,
considering the prevalence of CMB of patients with
stroke in general [21], it is comparable with the previous
reports, which suggested that the reported prevalence of
CMB was 34% (95% CI 31–36) in people with ischemico cerebral microbleeds
Unadjusted OR p-value† Adjusted OR p-value‡
1.00 (0.98-1.02) 0.96 0.99 (0.97-1.02) 0.51
0.99 (0.97-1.01) 0.41 0.99 (0.97-1.02) 0.58
0.29 0.49
Ref. Ref.
1.12 (0.53-2.34) 0.77 1.28 (0.57-2.90) 0.55
1.94 (0.82-4.59) 0.13 1.71 (0.64-4.62) 0.29
0.03 0.04
Ref. Ref.
1.45 (0.67-3.17) 0.35 1.62 (0.67-3.92) 0.28
3.05 (1.25-7.43) 0.01 3.81 (1.36-10.65) 0.01
e in parentheses.
nfidence interval.
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stroke patients was 64.7% in the previous hospital-based
study [22].
In the previous studies, 63 (11.0%) patients among 575
subjects with sustained hypertension who aged over 50
years were reverse dippers [6]. In the patient with acute
ischemic stroke, one study showed that 14 patients of 35
subjects (40.0%) were reverse dippers [23]. Another
study showed that reverse dippers were 44.4% of non-
lacunar stroke and 37.1% of lacunar stroke among con-
secutive patients with acute ischemic infarctions within
24 hours of symptom-onset [24]. One study that re-
corded blood pressure every 4 hours during 48 hours
following acute stroke showed 36.9% (64 among 173
subjects) were reverse dippers [25]. Though our results
might be comparable with or somewhat lower than the
previous studies with acute ischemic stroke, the preva-
lence seemed to vary according to underlying cardiovas-
cular risk factors and the timing of BP measurement.
There are several limitations in our study. A case can
be made to call into question the eligibility criteria of
our study. For the practical reason, we limited our study
to hypertensive patients. CMB were regarded as hyper-
tensive target organ disease [22], and more frequently
observed in the hypertensive patients. We assumed that
the effect size of dipping status on the CMB was modest;
we limited our study to the hypertensive stroke patients to
investigate the effect of dipping status on the CMB. If
normotensive patients were included, the presence of
hypertension might become another confounder for our
analysis. Thus, generalizability issue should be considered
when our results are interpreted.
After stroke, BP can show a reactive elevation due to in-
creased catecholamine levels and previous hypertension
and pain [18]; so the results could be biased because of
symptomatic stroke. However, we applied ABPM to the
subjects at least two weeks apart from their ictus. One
study using ABPM showed that BP normalized to the con-
trol value one week after ictus of thromboembolic, lacunar
infarctions, and intracerebral hemorrhages [26]. In another
study, the subjects with lacunar and large artery athero-
sclerosis infarctions showed a spontaneous SBP drop in the
first few hours [27]. We also considered the confounding
effect of rebound hypertension due to medication suspen-
sion after acute stroke. There were no significant differ-
ences in previous antihypertensive medication history
between CMB (+) vs. (−) groups. When we added this fac-
tor to our final adjusted model, OR was not compromised
and the significance remained (OR 3.81; 95% CI, 1.36-
10.65; p = 0.01).
Physical dependence caused by recent stroke could be
another confounding factor. However, when we compared
stroke severities using initial NIHSS between two groups,
there were no significant differences in the stroke severity.The small number of subjects should also be consid-
ered. Though there were statistical significances, the
small numbers of patients in the subgroups of dippers
and reverse dippers could actually weaken the strength
of our conclusion. The possibility of increased type I
error is another consideration of our study. When we
readjusted minimum p-value for statistical significances
using Bonferroni methods, the statistical significances
were mostly compromised. Considering the conserva-
tive nature of Bonferroni correction, there were some
possibilities that true associations were also compro-
mised by this correction. However we admit the possi-
bility of increased type I error, we thought that our
results should be validated through hypothesis-driven
research with larger sample size.
For practical reasons, we applied ABPM only once for
each patient. Ideally, a repetitive ABPM application would
increase data reliability; however, patient discomfort and
high application cost were too much to bear in actual prac-
tice. In addition to that, the possible confounding factors
such as sleep apnea were not measured. Finally, the cause-
effect association cannot be referred in the present study.
Conclusion
In conclusion, our study revealed that reverse dipping in
ABPM was significantly associated with high prevalence
of CMB in hypertensive patients with ischemic stroke.
This has an implication of underscoring the importance
of sustained nighttime hypertension for its association
with CMB, which represents hypertensive target organ
disease. Nighttime reverse dipping often goes unnoticed
by patients, and, or physicians. Strategies to overcome
these silent issues might be helpful in preventing CMB-
associated cerebrovascular diseases. In future research,
these associations should be reproduced and confirmed
in more generalized subjects.
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